bioelectronics corp (BIEL:OTC US)
bioelectronics corp (BIEL) Snapshot
|
Open
$0.0020
|
Previous Close
$0.0020
|
|
|
Day High
$0.0021
|
Day Low
$0.0019
|
|
|
52 Week High
06/11/12 - $0.0068
|
52 Week Low
12/27/12 - $0.0013
|
|
|
Market Cap
5.1M
|
Average Volume 10 Days
26.2M
|
|
|
EPS TTM
--
|
Shares Outstanding
2.4B
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
bioelectronics corp (BIEL) Related Businessweek News
No Related Businessweek News Foundbioelectronics corp (BIEL) Details
BioElectronics Corporation develops, manufactures, and markets drug–free, topical pain medical devices. Its products comprise ActiPatch therapy for over-the-counter treatment of back pain and other musculoskeletal complaints; Allay menstrual cycle pain therapy; RecoveryRx for chronic and post-operative wound care; and HealFast therapy, a drug-free therapy for healing of muscle and tendon injuries, sores, and incision in horses, cats, and dogs. The company markets and sells its products under the ActiPatch, Allay, and RecoveryRx brand names through distributors primarily in Korea, Singapore, Malaysia, Canada, Columbia, Scandinavia, Saudi Arabia, the Balkans, Australia, China, and South America. BioElectronics Corporation was founded in 2000 and is based in Frederick, Maryland.
bioelectronics corp (BIEL) Key Developments
BioElectronics Corporation announced that it has established distribution in Peru of its ActiPatch Therapy, treatment of back, knee, elbow and other pain and musculoskeletal issues, and its Allay menstrual cycle pain therapy.
BioElectronics Corporation reported unaudited earnings results for the year ended December 31, 2012. For the year, the company reported sales of $500,121 compared to $1,176,285 a year ago. Loss from operations was $1,954,304 compared to $2,442,090 a year ago. Loss before income taxes was $2,412,520 compared to $2,852,660 a year ago. Net loss was $2,412,520 or $0.0009 basic and diluted per share compared to $2,852,660 or $0.0017 basic and diluted per share a year ago.
BioElectronics Corporation begun product distribution of its ActiPatch(R) Musculoskeletal Pain Relief, Allay(TM) Menstrual Pain Therapy and RecoveryRx(TM) Chronic and Postoperative wound therapy brands with Herapharm Co. Ltd.
| Recently Viewed | |||
| BIEL:US | $0.00 USD | 0.0001 |  |
| Company | Last | Change |
| Diapulse Corp America/Del | $0.34 USD | 0.00 |
| Ivivi Technologies Inc | $0.0001 USD | 0.00 |
| View Industry Companies | ||
Industry Analysis
BIEL
Industry Average
| Valuation | BIEL | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 10.6x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact BIOELECTRONICS CORP, please visit www.bielcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
